Status:
TERMINATED
Concordance Between Central Blood PRessure dEvices In Nephrology Patients
Lead Sponsor:
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Conditions:
Hypertension
Chronic Kidney Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The most accurate way to determine intra-aortic BP is to obtain invasive measures by vascular catheterization, which is not possible to perform routinely during the regular follow-up of patients. Howe...
Eligibility Criteria
Inclusion
- \- Age 18-80 years old
Exclusion
- Ongoing atrial fibrillation
- Arm circumference incompatible with the blood pressure cuffs for all devices (\<18 cm or \> 50 cm)
- Incapacity to give consent
Key Trial Info
Start Date :
April 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 12 2024
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT05963880
Start Date
April 26 2021
End Date
November 12 2024
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital du Sacré-Coeur de Montréal
Montreal, Quebec, Canada, H4J1C5